{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T20:07:53Z","timestamp":1789157273667,"version":"build-2803163510"},"reference-count":55,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T00:00:00Z","timestamp":1777939200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100016060","name":"De Cock-Hadders Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100016238","name":"Ministerie van Economische Zaken en Klimaat","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100016238","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009950","name":"Royal Thai Government Ministry of Education","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009950","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016036","name":"Health~Holland","doi-asserted-by":"publisher","award":["UMCG PPP-2021-02"],"award-info":[{"award-number":["UMCG PPP-2021-02"]}],"id":[{"id":"10.13039\/100016036","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ard.eular.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of the Rheumatic Diseases"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.ard.2026.05.003","type":"journal-article","created":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T20:44:25Z","timestamp":1780001065000},"page":"1839-1853","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Single-cell multiomics reveals activation of the STAT3\u2013PIM1 axis in T-cell subsets in proteinase 3-ANCA\u2013positive granulomatosis with polyangiitis"],"prefix":"10.1016","volume":"85","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-1028-8403","authenticated-orcid":false,"given":"Nanthicha","family":"Inrueangsri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo G.","family":"Bonasia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin P.","family":"Mennega","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew A.","family":"Jackson-Wood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel J.","family":"Bullers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver","family":"Wood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malte","family":"Borggrewe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petya D.","family":"Marinova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rindert R.","family":"Venema","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theo","family":"Bijma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosanne D.","family":"Reitsema","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wayel H.","family":"Abdulahad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan-Stephan F.","family":"Sanders","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abraham","family":"Rutgers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Heeringa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ard.2026.05.003_bib0001","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/s41572-020-0204-y","article-title":"ANCA-associated vasculitis","volume":"6","author":"Kitching","year":"2020","journal-title":"Nat Rev Dis Primers"},{"issue":"5","key":"10.1016\/j.ard.2026.05.003_bib0002","doi-asserted-by":"crossref","first-page":"e314","DOI":"10.1016\/S2665-9913(24)00035-3","article-title":"Proteinase 3-specific antineutrophil cytoplasmic antibody-associated vasculitis","volume":"6","author":"Falde","year":"2024","journal-title":"Lancet Rheumatol."},{"issue":"1","key":"10.1016\/j.ard.2026.05.003_bib0003","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1136\/ard-2022-223764","article-title":"EULAR recommendations for the management of ANCA-associated vasculitis: 2022 update","volume":"83","author":"Hellmich","year":"2024","journal-title":"Ann Rheum Dis."},{"issue":"7","key":"10.1016\/j.ard.2026.05.003_bib0004","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1093\/ndt\/gfl097","article-title":"Persistent T-cell activation and clinical correlations in patients with ANCA-associated systemic vasculitis","volume":"21","author":"Marinaki","year":"2006","journal-title":"Nephrol Dial Transplant."},{"issue":"7","key":"10.1016\/j.ard.2026.05.003_bib0005","doi-asserted-by":"crossref","first-page":"2196","DOI":"10.1002\/art.23557","article-title":"Skewed distribution of Th17 lymphocytes in patients with Wegener's granulomatosis in remission","volume":"58","author":"Abdulahad","year":"2008","journal-title":"Arthritis Rheum."},{"issue":"3","key":"10.1016\/j.ard.2026.05.003_bib0006","doi-asserted-by":"crossref","first-page":"R70","DOI":"10.1186\/ar4247","article-title":"Increased frequency of circulating IL-21 producing Th-cells in patients with granulomatosis with polyangiitis (GPA)","volume":"15","author":"Abdulahad","year":"2013","journal-title":"Arthritis Res Ther."},{"key":"10.1016\/j.ard.2026.05.003_bib0007","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2024.103236","article-title":"Circulating immune profile in granulomatosis with polyangiitis reveals distinct patterns related to disease activity","volume":"146","author":"Bonasia","year":"2024","journal-title":"J Autoimmun."},{"issue":"5","key":"10.1016\/j.ard.2026.05.003_bib0008","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1038\/sj.ki.5001670","article-title":"Persistent expansion of CD4+ effector memory T cells in Wegener's granulomatosis","volume":"70","author":"Abdulahad","year":"2006","journal-title":"Kidney Int."},{"issue":"1","key":"10.1016\/j.ard.2026.05.003_bib0009","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1186\/ar2923","article-title":"T cells in ANCA-associated vasculitis: what can we learn from lesional versus circulating T cells?","volume":"12","author":"Wilde","year":"2010","journal-title":"Arthritis Res Ther."},{"issue":"5","key":"10.1016\/j.ard.2026.05.003_bib0010","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1016\/S0002-9440(10)61118-2","article-title":"Peripheral blood and granuloma CD4(+)CD28(-) T cells are a major source of interferon-gamma and tumor necrosis factor-alpha in Wegener's granulomatosis","volume":"160","author":"Komocsi","year":"2002","journal-title":"Am J Pathol."},{"issue":"3","key":"10.1016\/j.ard.2026.05.003_bib0011","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1111\/j.1365-2249.1991.tb05647.x","article-title":"Predominance of IgG1 and IgG4 subclasses of anti-neutrophil cytoplasmic autoantibodies (ANCA) in patients with Wegener's granulomatosis and clinically related disorders","volume":"83","author":"Brouwer","year":"1991","journal-title":"Clin Exp Immunol."},{"issue":"1","key":"10.1016\/j.ard.2026.05.003_bib0012","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/s13073-017-0467-4","article-title":"A practical guide to single-cell RNA-sequencing for biomedical research and clinical applications","volume":"9","author":"Haque","year":"2017","journal-title":"Genome Med."},{"key":"10.1016\/j.ard.2026.05.003_bib0013","doi-asserted-by":"crossref","DOI":"10.1038\/srep44447","article-title":"Abseq: Ultrahigh-throughput single cell protein profiling with droplet microfluidic barcoding","volume":"7","author":"Shahi","year":"2017","journal-title":"Sci Rep."},{"issue":"11","key":"10.1016\/j.ard.2026.05.003_bib0014","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1038\/s41577-024-01043-3","article-title":"Single-cell analysis in rheumatic and allergic diseases: insights for clinical practice","volume":"24","author":"Nishide","year":"2024","journal-title":"Nat Rev Immunol."},{"issue":"7","key":"10.1016\/j.ard.2026.05.003_bib0015","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1038\/s41590-019-0378-1","article-title":"Defining inflammatory cell states in rheumatoid arthritis joint synovial tissues by integrating single-cell transcriptomics and mass cytometry","volume":"20","author":"Zhang","year":"2019","journal-title":"Nat Immunol."},{"issue":"6589","key":"10.1016\/j.ard.2026.05.003_bib0016","doi-asserted-by":"crossref","first-page":"eabf1970","DOI":"10.1126\/science.abf1970","article-title":"Single-cell RNA-seq reveals cell type-specific molecular and genetic associations to lupus","volume":"376","author":"Perez","year":"2022","journal-title":"Science."},{"issue":"1","key":"10.1016\/j.ard.2026.05.003_bib0017","doi-asserted-by":"crossref","first-page":"3581","DOI":"10.1038\/s41467-025-58550-7","article-title":"Neutrophil single-cell analysis identifies a type II interferon-related subset for predicting relapse of autoimmune small vessel vasculitis","volume":"16","author":"Nishide","year":"2025","journal-title":"Nat Commun."},{"key":"10.1016\/j.ard.2026.05.003_bib0018","doi-asserted-by":"crossref","DOI":"10.2147\/JIR.S545080","article-title":"Single-cell RNA-sequencing of peripheral blood reveals neutrophil heterogeneity in childhood ANCA-associated vasculitis","volume":"19","author":"Wei","year":"2026","journal-title":"J Inflamm Res."},{"issue":"1","key":"10.1016\/j.ard.2026.05.003_bib0019","doi-asserted-by":"crossref","first-page":"5789","DOI":"10.1038\/s41467-023-41328-0","article-title":"Single-cell multi-omics analysis identifies two distinct phenotypes of newly-onset microscopic polyangiitis","volume":"14","author":"Nishide","year":"2023","journal-title":"Nat Commun."},{"issue":"1","key":"10.1016\/j.ard.2026.05.003_bib0020","doi-asserted-by":"crossref","first-page":"8220","DOI":"10.1038\/s41467-024-52525-w","article-title":"Immune profiling-based targeting of pathogenic T cells with ustekinumab in ANCA-associated glomerulonephritis","volume":"15","author":"Engesser","year":"2024","journal-title":"Nat Commun."},{"issue":"1","key":"10.1016\/j.ard.2026.05.003_bib0021","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/art.37715","article-title":"2012 Revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides","volume":"65","author":"Jennette","year":"2013","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.ard.2026.05.003_bib0022","doi-asserted-by":"crossref","first-page":"2170","DOI":"10.3389\/fimmu.2019.02170","article-title":"Increased miR-142-3p expression might explain reduced regulatory T cell function in granulomatosis with polyangiitis","volume":"10","author":"Dekkema","year":"2019","journal-title":"Front Immunol."},{"issue":"1","key":"10.1016\/j.ard.2026.05.003_bib0023","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s13059-017-1382-0","article-title":"SCANPY: large-scale single-cell gene expression data analysis","volume":"19","author":"Wolf","year":"2018","journal-title":"Genome Biol."},{"key":"10.1016\/j.ard.2026.05.003_bib0024","article-title":"PIM1 signaling in immunoinflammatory diseases: an emerging therapeutic target","volume":"15","author":"Yang","year":"2024","journal-title":"Front Immunol."},{"issue":"4","key":"10.1016\/j.ard.2026.05.003_bib0025","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1038\/nsmb.2519","article-title":"SOCS3 binds specific receptor-JAK complexes to control cytokine signaling by direct kinase inhibition","volume":"20","author":"Kershaw","year":"2013","journal-title":"Nat Struct Mol Biol."},{"issue":"1","key":"10.1016\/j.ard.2026.05.003_bib0026","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1002\/med.21284","article-title":"The PIM family of serine\/threonine kinases in cancer","volume":"34","author":"Narlik-Grassow","year":"2014","journal-title":"Med Res Rev."},{"issue":"7","key":"10.1016\/j.ard.2026.05.003_bib0027","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1002\/art.40471","article-title":"Brief Report: circulating cytokine profiles and antineutrophil cytoplasmic antibody specificity in patients with antineutrophil cytoplasmic antibody-associated vasculitis","volume":"70","author":"Berti","year":"2018","journal-title":"Arthritis Rheumatol."},{"issue":"10","key":"10.1016\/j.ard.2026.05.003_bib0028","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1002\/art.41744","article-title":"Pim kinases as therapeutic targets in early rheumatoid arthritis","volume":"73","author":"Maney","year":"2021","journal-title":"Arthritis Rheumatol."},{"issue":"1","key":"10.1016\/j.ard.2026.05.003_bib0029","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s12943-023-01721-1","article-title":"Targeting Pim kinases in hematological cancers: molecular and clinical review","volume":"22","author":"Bellon","year":"2023","journal-title":"Mol Cancer."},{"issue":"12","key":"10.1016\/j.ard.2026.05.003_bib0030","first-page":"4085","article-title":"The role of Pim kinase in immunomodulation","volume":"10","author":"Liu","year":"2020","journal-title":"Am J Cancer Res."},{"issue":"6","key":"10.1016\/j.ard.2026.05.003_bib0031","doi-asserted-by":"crossref","first-page":"3123","DOI":"10.3390\/ijms25063123","article-title":"PIM kinases as potential biomarkers and therapeutic targets in inflammatory arthritides","volume":"25","author":"Assirelli","year":"2024","journal-title":"Int J Mol Sci."},{"issue":"223","key":"10.1016\/j.ard.2026.05.003_bib0032","doi-asserted-by":"crossref","first-page":"223ra22","DOI":"10.1126\/scitranslmed.3007217","article-title":"Integrative biology approach identifies cytokine targeting strategies for psoriasis","volume":"6","author":"Perera","year":"2014","journal-title":"Sci Transl Med."},{"issue":"2","key":"10.1016\/j.ard.2026.05.003_bib0033","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.cellimm.2011.10.011","article-title":"The role of PIM kinases in human and mouse CD4+ T cell activation and inflammatory bowel disease","volume":"272","author":"Jackson","year":"2012","journal-title":"Cell Immunol."},{"issue":"8","key":"10.1016\/j.ard.2026.05.003_bib0034","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1002\/art.40863","article-title":"Pim-1 as a therapeutic target in lupus nephritis","volume":"71","author":"Fu","year":"2019","journal-title":"Arthritis Rheumatol."},{"issue":"1","key":"10.1016\/j.ard.2026.05.003_bib0035","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1093\/rheumatology\/key261","article-title":"PIM-1 kinase is a novel regulator of proinflammatory cytokine-mediated responses in rheumatoid arthritis fibroblast-like synoviocytes","volume":"58","author":"Ha","year":"2019","journal-title":"Rheumatology (Oxford)."},{"issue":"1","key":"10.1016\/j.ard.2026.05.003_bib0036","doi-asserted-by":"crossref","first-page":"5866","DOI":"10.1038\/s41467-022-33502-7","article-title":"Multicellular immune dynamics implicate PIM1 as a potential therapeutic target for uveitis","volume":"13","author":"Li","year":"2022","journal-title":"Nat Commun."},{"issue":"5","key":"10.1016\/j.ard.2026.05.003_bib0037","doi-asserted-by":"crossref","first-page":"3048","DOI":"10.1074\/jbc.M112.361709","article-title":"Proviral integration site for Moloney murine leukemia virus (PIM) kinases promote human T helper 1 cell differentiation","volume":"288","author":"Tahvanainen","year":"2013","journal-title":"J Biol Chem."},{"issue":"12","key":"10.1016\/j.ard.2026.05.003_bib0038","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2023.113469","article-title":"PIM kinases regulate early human Th17 cell differentiation","volume":"42","author":"Buchacher","year":"2023","journal-title":"Cell Rep."},{"issue":"39","key":"10.1016\/j.ard.2026.05.003_bib0039","doi-asserted-by":"crossref","first-page":"26872","DOI":"10.1074\/jbc.M114.586651","article-title":"PIM1 kinase phosphorylates the human transcription factor FOXP3 at serine 422 to negatively regulate its activity under inflammation","volume":"289","author":"Li","year":"2014","journal-title":"J Biol Chem."},{"issue":"2","key":"10.1016\/j.ard.2026.05.003_bib0040","doi-asserted-by":"crossref","first-page":"140","DOI":"10.3892\/br.2015.561","article-title":"Pim-1 kinase as cancer drug target: an update","volume":"4","author":"Tursynbay","year":"2016","journal-title":"Biomed Rep."},{"issue":"3","key":"10.1016\/j.ard.2026.05.003_bib0041","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.cyto.2009.07.003","article-title":"STAT3 in CD4+ T helper cell differentiation and inflammatory diseases","volume":"47","author":"Egwuagu","year":"2009","journal-title":"Cytokine"},{"issue":"9","key":"10.1016\/j.ard.2026.05.003_bib0042","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/j.exphem.2016.06.003","article-title":"IL-2, IL-7, and IL-15: multistage regulators of CD4(+) T helper cell differentiation","volume":"44","author":"Read","year":"2016","journal-title":"Exp Hematol."},{"key":"10.1016\/j.ard.2026.05.003_bib0043","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1600754","article-title":"The plasma proteome reveals distinct signaling pathways associated with PR3-ANCA positive and MPO-ANCA positive vasculitis","volume":"16","author":"Hellbacher","year":"2025","journal-title":"Front Immunol."},{"issue":"2","key":"10.1016\/j.ard.2026.05.003_bib0044","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1136\/annrheumdis-2014-205850","article-title":"IL-6-driven STAT signalling in circulating CD4+ lymphocytes is a marker for early anticitrullinated peptide antibody-negative rheumatoid arthritis","volume":"75","author":"Anderson","year":"2016","journal-title":"Ann Rheum Dis."},{"issue":"6","key":"10.1016\/j.ard.2026.05.003_bib0045","doi-asserted-by":"crossref","first-page":"2080","DOI":"10.1002\/art.22692","article-title":"Functional defect of circulating regulatory CD4+ T cells in patients with Wegener\u2019s granulomatosis in remission","volume":"56","author":"Abdulahad","year":"2007","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.ard.2026.05.003_bib0046","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1470488","article-title":"Update on tocilizumab in rheumatoid arthritis: a narrative review","volume":"16","author":"Parisi","year":"2025","journal-title":"Front Immunol."},{"issue":"2","key":"10.1016\/j.ard.2026.05.003_bib0047","doi-asserted-by":"crossref","first-page":"rkac037","DOI":"10.1093\/rap\/rkac037","article-title":"Benchmarking tocilizumab use for giant cell arteritis","volume":"6","author":"Conway","year":"2022","journal-title":"Rheumatol Adv Pract."},{"issue":"10","key":"10.1016\/j.ard.2026.05.003_bib0048","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1007\/s10067-017-3752-0","article-title":"Current clinical evidence of tocilizumab for the treatment of ANCA-associated vasculitis: a prospective case series for microscopic polyangiitis in a combination with corticosteroids and literature review","volume":"36","author":"Sakai","year":"2017","journal-title":"Clin Rheumatol."},{"issue":"1","key":"10.1016\/j.ard.2026.05.003_bib0049","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.semarthrit.2015.02.002","article-title":"Interleukin-6 in ANCA-associated vasculitis: rationale for successful treatment with tocilizumab","volume":"45","author":"Berti","year":"2015","journal-title":"Semin Arthritis Rheum."},{"issue":"5","key":"10.1016\/j.ard.2026.05.003_bib0050","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1007\/s40265-017-0701-9","article-title":"JAK-STAT signaling as a target for inflammatory and autoimmune diseases: current and future prospects","volume":"77","author":"Banerjee","year":"2017","journal-title":"Drugs."},{"issue":"8","key":"10.1016\/j.ard.2026.05.003_bib0051","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.3899\/jrheum.221219","article-title":"Response to treatment with tofacitinib in 11 patients with refractory granulomatosis with polyangiitis","volume":"50","author":"Linde","year":"2023","journal-title":"J Rheumatol"},{"issue":"12","key":"10.1016\/j.ard.2026.05.003_bib0052","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1136\/annrheumdis-2021-220484","article-title":"Tofacitinib for the treatment of antineutrophil cytoplasm antibody-associated vasculitis: a pilot study","volume":"80","author":"Liu","year":"2021","journal-title":"Ann Rheum Dis."},{"key":"10.1016\/j.ard.2026.05.003_bib0053","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.ejmech.2019.03.050","article-title":"PIM kinase inhibitors: structural and pharmacological perspectives","volume":"172","author":"Asati","year":"2019","journal-title":"Eur J Med Chem."},{"key":"10.1016\/j.ard.2026.05.003_bib0054","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1182\/blood-2024-200312","article-title":"Nuvisertib (TP-3654), an investigational selective PIM1 kinase inhibitor, showed durable clinical response and sustained hematological improvement in relapsed\/refractory myelofibrosis patients","volume":"144","author":"El Chaer","year":"2024","journal-title":"Blood."},{"issue":"4","key":"10.1016\/j.ard.2026.05.003_bib0055","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1002\/art.70061","article-title":"The effect of intranasal niclosamide on nasal symptoms in patients with antineutrophil cytoplasmic antibody-associated vasculitis","volume":"78","author":"Lim","year":"2026","journal-title":"Arthritis Rheumatol."}],"container-title":["Annals of the Rheumatic Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496726002797?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496726002797?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T19:19:53Z","timestamp":1789154393000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003496726002797"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":55,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S0003496726002797"],"URL":"https:\/\/doi.org\/10.1016\/j.ard.2026.05.003","relation":{},"ISSN":["0003-4967"],"issn-type":[{"value":"0003-4967","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Single-cell multiomics reveals activation of the STAT3\u2013PIM1 axis in T-cell subsets in proteinase 3-ANCA\u2013positive granulomatosis with polyangiitis","name":"articletitle","label":"Article Title"},{"value":"Annals of the Rheumatic Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ard.2026.05.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier B.V. on behalf of European Alliance of Associations for Rheumatology (EULAR).","name":"copyright","label":"Copyright"}]}}